Home › NDC Lookup › RxCUI directory › RxCUI 430551

Benznidazole 100 MG Oral Tablet — RxCUI 430551

RxNorm drug concept · Semantic clinical drug
RxCUI 430551 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI430551
Official nameBenznidazole 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Benznidazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Chagas disease is a parasitic infection caused by a tiny organism called Trypanosoma cruzi, usually spread through insect bites. Benznidazole is an antibiotic that targets this par...
  • What is benznidazole actually treating? My child tested positive for something called Chagas disease.
  • Not necessarily. The 100 mg tablets are scored, so they can be split into smaller pieces for an accurate weight-based dose. Both the 12.5 mg and 100 mg tablets can also be dissolve...
  • How do I give this to my child — do they have to swallow a whole tablet?
📖 Read our full Benznidazole guide →

🕸️ Concept Web — How Benznidazole 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benznidazole 100 MG Oral Tablet RxCUI 430551

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Benznidazole 18994
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benznidazole Oral Tablet 437846
    • Benznidazole Oral Product 1160537
    • Benznidazole Pill 1160538
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Benznidazole 100 MG 437845

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benznidazole 100 MG SCDC · 437845
  • Benznidazole Oral Tablet SCDF · 437846
  • Benznidazole Oral Product SCDG · 1160537
  • Benznidazole Pill SCDG · 1160538

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 430551 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00642-7463-12 1 BOTTLE in 1 CARTON (0642-7463-12) / 100 TABLET in 1 BOTTL... Benznidazole Exeltis USA, Inc. 2018-03-30
00642-7464-10 1 BOTTLE in 1 CARTON (0642-7464-10) / 100 TABLET in 1 BOTTL... Benznidazole Exeltis USA, Inc. 2018-03-30
Observed labelers: Exeltis USA, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.